About Servier
Servier is a company based in Suresnes (France) founded in 1954. The company has 3 employees. Servier has completed 3 acquisitions, including Day One, Groupe REALITES and Servier Symphogen. Servier offers products and services including Cancer Treatments, Cardio-metabolism Products, and Neurology Treatments.
- Headquarter Suresnes, France
- Employees 3
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website servier.com
- Social LinkedIn X Facebook Instagram
- Legal Name Servier Danmark A/S
- Annual Revenue$4.6 M (USD)27as on Sep 30, 2022
- Latest Funding Round$912.74K (USD), Grant
Feb 2022
- Investors
- Employee Count3
- Investments & AcquisitionsDay One
& 2 more
Products & Services of Servier
Servier offers a comprehensive portfolio of products and services, including Cancer Treatments, Cardio-metabolism Products, and Neurology Treatments.
Medications targeting cancers through innovative research
Solutions for heart and metabolic conditions
Drugs for neurological disorders and patient care
Funding Insights of Servier
- Total Rounds 2
- Last Round Grant — $912,744
- First Round $454.19M
(Jul 2019)
- Investors Count 1
All 2 funding rounds of Servier with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | $912,744 | Grant | – | – | |
| Jul 2019 | $454.19M | Debt – Conventional | – | – | – |
1 investors in total: 1 institutional.
Investors in Servier
Servier has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ministry of Economy, Finance and Industrial and Digital Sovereignty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | economie.gouv.fr | - |
Investor details for Servier
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Servier
89 people are tracked at Servier (30 in leadership, 59 in team); the tracked headcount is 3.
| Name | Role | Group |
|---|---|---|
Olivier Laureau | President | Leadership |
Marie Hazard | Transformation Portfolio And Performance Director | Leadership |
Eva Calichiama | Corporate Program Support Director | Leadership |
Arturo Lucas | Legal & Compliance Director / Global Data Privacy Committee / European Public Affairs Network | Leadership |
Grégory Ruget | Group Program Support Director, Group Transformation & Programs Office | Leadership |
Fassi-Fehri Jawad | Legal Department- Head Of Corporate And Finance Department | Leadership |
Mervat Amin | Head Of Compliance | Leadership |
Gregoire Guillet | Chief Business And Value Officer At Wehealth By Servier | Leadership |
Benjamin di Cara | Chief Of Staff | Leadership |
Francesco Campione | Legal And Compliance Director | Leadership |
Anne-Lise Doucement | Group Deputy Legal Director / Directeur Juridique Adjoint Groupe | Leadership |
Valérie Brunner | Executive Director, Head Of R&d Transformation Office & Chief Of Staff | Leadership |
Arnaud Lucien | R&d Project Director | Leadership |
Frederic Lieutaud | Commercial Coordination Director Generic Division | Leadership |
Pascal Brière | Executive Vice President Generics Activities | Leadership |
Oswald Seidowsky | Head Of Purchase Legal Operations | Leadership |
Joseph Divinagracia | Deputy General Counsel, Global Head Of Intellectual Property Litigation | Leadership |
Meriem Loudiyi | Director Of Trademarks And Anti-falsification Department - LES Laboratoires Servier | Leadership |
Ronald Rooke | Alliance Manager Project Director | Leadership |
Sandrine Perez | Senior Director, Global Head Of CMC Project Management Office | Leadership |
69 more people are available in the full profile.
Complete people profiles for Servier
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Servier
Servier has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Day One, Groupe REALITES and Servier Symphogen.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Investigational cancer drugs, including pan-RAF inhibitors, are developed. | dayonebio.com | San Francisco, United States | 2018 | Mar 2026 | $2.5B | |
Servier Symphogen is focused on developing antibody therapeutics for cancer. | symphogen.com | Ballerup, Denmark | 2000 | Apr 2020 | •••• | |
Real estate development and management are conducted in France. | groupe-realites.com | Saint Herblain, France | 2003 | Jun 2011 | •••• |
Complete acquisition details for Servier
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Servier
6 dated milestones of Servier across 72 years, from founding to its latest funding, stage changes and deals.
- Founded Servier is founded.
- Acquisition Acquires Groupe REALITES.
- Funding First funding round of $454.2M.
- Acquisition Acquires Servier Symphogen.
- Funding Latest funding round, Grant, of $913K.
- Acquisition Acquires Day One.
Web traffic of Servier
The website of Servier (servier.com) receives about 306.8K visits a month and ranks #150,173 among all websites worldwide, #4,652 in Biotechnology and Pharmaceuticals.
- Monthly visits306.8K
▲ 2.7% vs previous month
- Unique visitors114.1K
per month
- Global rank#150,173
among all websites
- Category rank#4,652
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit2.9
- Average visit1 min 38 sec
- DevicesDesktop 51% · Mobile 49%
Websites whose visitors overlap most with Servier. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| astrazeneca.com | 100% | 1.3M | #48,983 | View details | |
rotta.com | rotta.com | 92% | – | – | – |
| novartis.com | 76% | 948.8K | #58,822 | View details | |
janssen-cilag.com | janssen-cilag.com | 76% | – | – | – |
| pfizer.com | 74% | 1.9M | #24,984 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Servier
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Servier
Complete news archive for Servier
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Servier
10 companies that operate in the same segment as Servier (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Servier
Servier was founded in 1954 and raised its 1st funding round 65 years after it was founded.
Servier is headquartered in Suresnes, France. It is registered at Suresnes, Ile-de-france, France.
Servier has 3 employees.
Annual revenue of Servier is $4.6M as on Sep 30, 2022.
Servier was established in 1954 in Suresnes, France, within the pharmaceuticals sector. Therapies are developed for cancers, cardio-metabolic conditions, and neurological disorders, with emphasis on precision medicine and targeted treatments. Generic drugs are provided alongside these innovations. Operations encompass the full drug lifecycle, from research and development to access and surveillance, while patient requirements are addressed throughout. Collaborations in research and development are pursued actively.
Servier offers Cancer Treatments, Cardio-metabolism Products, and Neurology Treatments.
Servier has made 3 acquisitions, including Day One, Groupe REALITES, and Servier Symphogen.
Servier has 1 investor. Key investors include Ministry of Economy, Finance and Industrial and Digital Sovereignty.
Servier operates through Servier Danmark A/S.
The website of Servier receives about 307 thousand visits a month and ranks #150,173 among all websites worldwide.